Icelandic Medicines Agency

Quality and safety of medicines and medical devices for patients and the general public

Development

Scientific Advice

The Icelandic Medicines Agency (IMA) provides scientific advice concerning the development of medicinal products.

Marketing Authorisations

RMS request

The IMA acts as Reference Member State in DC-procedures

News

Access to Drugs that are not on the Icelandic Market

Guidelines have been issued to clarify the different processes that provide access to drugs that are not marketed in Iceland or do not have marketing authorization in the EEA. Among other things, it discusses compassionate use (CU) and named patient use (NPP).

Submissions for marketing authorisations

DCP with Iceland as RMS. Third quarter of 2025 now open

Submissions for marketing authorisations

DCP with Iceland as RMS

Adverse reactions are harmful and unintended or undesirable effects of the drug. Anyone can report a side effect of a medicine to the Icelandic Medicines Agency!

75

Pharmacies

The Icelandic Medicines Control Agency supervises all pharmacies and pharmacies as well as their branches.
2.916

Medicines on market

Medicines can be placed on the market after receiving a marketing authorization from the Icelandic Medicines Agency.
3.697

Number of packages in the price list

Number of packages that are currently on the market and available in Iceland

LiveChat